14
Participants
Start Date
February 28, 2020
Primary Completion Date
April 11, 2022
Study Completion Date
April 11, 2022
Oxycodone
5 mg tablet
Placebo
Oxycodone-matched placebo tablet
EyeLink 1000 Plus
Non-invasive video-based eye tracking system
Oculo-Cognitive Addition test (OCAT)
Subject will have to look for numbers on a screen and add these numbers together. OCAT will be presented on a computer screen with attached eye tracking device at the bottom part.
VT3mini - Eye Tracking Technology for OEMs
Non-invasive eye-tracking device
Mayo Clinic in Arizona, Scottsdale
Lead Sponsor
Mayo Clinic
OTHER